4-Aminoquinolines: Novel Nociceptin
Antagonists with Analgesic Activity
by
Shinkai H, Ito T, Iida T, Kitao Y, Yamada H, Uchida I
Central Pharmaceutical Research Institute,
JT Inc., 1-1 Murasaki-cho,
Takatsuki, Osaka 569-1125, Japan.
J Med Chem 2000 Nov 30; 43(24):4667-4677

ABSTRACT

Small-molecule nociceptin antagonists were synthesized to examine their therapeutic potential. After a 4-aminoquinoline derivative was found to bind with the human ORL(1) receptor, a series of 4-aminoquinolines and related compounds were synthesized and their binding was evaluated. Elucidation of structure-activity relationships eventually led to the optimum compounds. One of these compounds, N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide hydrochloride (11) not only antagonized nociceptin-induced allodynia in mice but also showed analgesic effect in a hot plate test using mice and in a formalin test using rats. Its analgesic effect was not antagonized by the opioid antagonist naloxone. These results indicate that this nociceptin antagonist has the potential to become a novel type of analgesic that differs from mu-opioid agonists.

Pain
LAAM
Morphine
Tramadol
Nocistatin
Nociceptin
Pain ethics
Endomorphins
Novelty and pain
Receptor subtypes
Fentanyl and ketamine
Opioids, mood and cognition
Orphanin/nociceptin: history
Nociceptin/orphanin and dopamine
Nociceptin antagonists as antidepressants

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family